)
Verrica Pharmaceuticals (VRCA) investor relations material
Verrica Pharmaceuticals Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for June 5, 2026, at company headquarters in West Chester, PA.
Shareholders are invited to vote on key proposals, including director elections and executive compensation.
Voting matters and shareholder proposals
Election of two directors: Paul B. Manning and Lawrence Eichenfield.
Advisory vote on the compensation of named executive officers.
Ratification of KPMG LLP as independent auditor for fiscal year ending December 31, 2026.
Approval of the Amended and Restated 2018 Equity Incentive Plan.
Other business may be addressed as appropriate during the meeting.
Board of directors and corporate governance
Board recommends voting in favor of all proposals, including director nominees and compensation matters.
- Proxy covers director elections, executive pay, auditor ratification, and equity plan overhaul.VRCA
Proxy filing20 Apr 2026 - Strong commercial growth and advancing late-stage pipeline position the company for major catalysts.VRCA
25th Annual Needham Virtual Healthcare Conference15 Apr 2026 - Strong revenue growth, late-stage pipeline progress, and global expansion drive future potential.VRCA
Corporate presentation30 Mar 2026 - Revenue up 370% in 2025, net loss narrowed, debt repaid, and YCANTH sales nearly doubled.VRCA
Q4 202511 Mar 2026 - YCANTH's relaunch drives strong adoption, pipeline advances, and global expansion opportunities.VRCA
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - Strong revenue growth and late-stage pipeline drive expansion in dermatology markets.VRCA
Investor presentation2 Mar 2026 - Cost reductions, expanded access, and pipeline progress drive growth and market opportunity.VRCA
The Citizens JMP Life Sciences Conference 20253 Feb 2026 - Strong Q1 growth and expanded access position YCANTH for accelerated adoption in 2024.VRCA
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - Q2 revenue hit $5.2M, net loss was $17.2M, and VP-315 showed strong Phase 2 results.VRCA
Q2 20241 Feb 2026
Next Verrica Pharmaceuticals earnings date
Next Verrica Pharmaceuticals earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage